Biosite Should Enroll Elderly With Concomitant Illness In CHF Studies - Panel

Biosite Diagnostics should enroll elderly people who may have various types of coronary disease or renal insufficiency in order to validate claims that the Triage B-Type Natriuretic Peptide (BNP) point-of-care test effectively diagnoses congestive heart failure (CHF) in at-risk populations, FDA's Clinical Chemistry and Clinical Toxicology Devices Panel recommended March 24 in Rockville, Maryland.